The Effect of Proprioceptive Neuromuscular Facilitation (PNF) Technique for Children With Chronic Pulmonary Diseases.

Sponsor
Istanbul University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03420209
Collaborator
(none)
40
1
2
68
0.6

Study Details

Study Description

Brief Summary

Cystic fibrosis and bronchiectasis are the most seen problems in children with chronic pulmonary diseases. İt is a genetic, chronic system disease that reduces life expectancy, and life quality as well. Chronic lung disease , malnutrition, and reduced activity, caused by disease lead to postural disorders. Muscle force, endurance, activity of Daily living are adversely affected. İn the treatment pulmonary rehabilitation are using. Airway clearance technique, pulmonary exercises, upper extremity ergometer, dumbbells, elastic bands, proprioceptive neuromuscular facilitation technique are applying. Resistance training using elastic bands has become an increasingly common intervention aiming to improve function by increasing muscular strength. İn one study indicated that muscle strength can be improved through three dimensional spiral large scale resistive exercises using proprioceptive neuromuscular facilitation. İn the literature there isn't any research , uses elastic bands with proprioceptive neuromuscular facilitation for the upper extremity and evaluating pulmonary functions, posture, quality of life, muscle force.

The aim of this study is giving exercises programme with proprioceptive neuromuscular facilitation and elastic bands and to evaluate pulmonary muscle force, pulmonary functions, posture, activity of daily living, quality of life, functional capacity. And to evaluate the effect of treatment programme on these parameters.

The subjects were divided in two groups. An experimental group three times a week for 12 weeks will perform proprioceptive neuromuscular facilitation exercises with elastic bands, and pulmonary exercises. The control group will apply only pulmonary exercises at home programme.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Group applying PNF technique
N/A

Detailed Description

Participants: All participants with chronic respiratory disease were recruited from a Istanbul University Medical Faculty, Allergy Department. All treatments were performed in the same hospital.

Sample Size: Sample size was calculated with power analysis. Pass 11 Home programme was used. α=0,05, β=0,6, 1- β=0,94 was determined. İf Sample size was defined 20 experimental and 20 control group the power obtained %95. Using two-sided two sample t-test with alpha 0,05 standard deviations were 5,0 and 4,0.

Procedure: Forty chronic respiratory disease patient were assessed between the age of 10-18 years old. The patients were found to be suitable for inclusion criteria of the study.Randomisation was performed by using randomisation function of Microsoft Office Excel programme by another researcher (ARO). Random number generator of Microsoft Office Excel Software gave a random number between 0 and 1 to the each treatment columns which were created by ARO. Sorting the random number row from the largest to the smallest number was performed by the sort and filter menu.After the randomisation,assessments at baseline and the patients were divided two groups. The experimental group was treated one by one with one physical therapist three times a week during a session for 30-45 minutes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effect of Proprioceptive Neuromuscular Facilitation Technique on Respiratory Functions, Functional Capacity, Muscle Force, Posture, Activity of Daily Living, Quality of Life for Children With Chronic Pulmonary Diseases.
Actual Study Start Date :
Dec 1, 2016
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group applying PNF technique

The experimental goup who are applying PNF technique with elastic bands for the upper extremities. Before the group will perform stretching and resisted exercises at the warming up period, after they will do PNF exercises with elastic bands on two PNF pattern for the upper extremities and finally they will do some stretching exercises for the cool down period. The programme will continue for 30-45 minutes, three times a week, for 12 weeks. They will work one by one with a physical therapist.

Behavioral: Group applying PNF technique

No Intervention: Home Programme

This group will perform only breathing exercises daily at home during 12 weeks.

Outcome Measures

Primary Outcome Measures

  1. Pulmonary function test [12 weeks]

    This test evaluates respiratory functions. Dynamic pulmonary volumes will evaluate.

Secondary Outcome Measures

  1. Posture Analysis [12 weeks]

    Plonk image measurement system is a posture analysis method evaluated on the computer software programme. We place the markers on the anatomic points of the body. We take a Picture with the camera. There is a 3 meter distance with the camera and the child. We take a Picture three times on the sagittal, frontal and lateral side.

  2. 6 Minutes Walk Test [12 weeks]

    This test was used to evaluate functional capacity. They are walking during six minutes on the corridor of 30 m. İf there is a fatigue they can have a rest. And they can continue to walk. We have to measure the distance of walking during six minutes. Before and after the test we have to measure the dyspnea and level of fatigue with perceived exertion scale.

  3. 6 Minutes Pegboard and Ring Test [12 weeks]

    İt measures functional capacity on the upper extremities of the body. Briefly, subjects were asked to move as many rings (each ring weighed 50 g; Zhan et al had used rings weighing half an ounce) as possible in 6 minutes, and the score was the number of rings moved during the 6-minute period. Pulse oxygen saturation was measured during the test. Scores for dyspnea were evaluated using a modified perceived exertion scale (0-10)13 immediately after the test.

  4. The Pediatric Quality of Life Inventory (PedsQ-L)test [12 weeks]

    This was used to measure quality of life for children. There are subgroups measuring physically, social, sensory and the problems living at school.

  5. Muscle testing [12 weeks]

    Muscle testing with the hand held dynamometer. Upper extremity muscle force will evaluate with the dynamometer.

  6. Maximal inspiratory pressure and Maximal expiratory pressure measurement [12 weeks]

    Maximal inspiratory pressure and Maximal expiratory pressure will measure the respiratory muscle force with the Micro respiratory pressure measure.

  7. Glitter-Activity of Daily Living test, Activity of Daily living measurement [12 weeks]

    In this test the patient reports the activities that promote discomfort during daily living activities. During its execution, functional capacity is evaluated by the time spent to perform a circuit that consists of global activities as walking, climbing up-and-down stairs, and trunk and upper limbs movements. The lower time spent the better is the functional condition. This test will measure functional capacity and easy to use.

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients between the ages of 10-18 years

  2. Walking alone

  3. The children with chronic pulmonary diseases who can cooperate

  4. Children who can accommodate to the programme

  5. The family who gave informed consent

  6. The children who are didn't at the acute exacerbation attack.

Exclusion Criteria:
  1. The children can't walk alone

  2. The children with chronic pulmonary diseases who can't cooperate

  3. The family who didn't gave informed consent

  4. The children who are at the acute exacerbation attack.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gamze Baskent Istanbul Turkey 34272

Sponsors and Collaborators

  • Istanbul University

Investigators

  • Study Director: Zerrin Dr Yigit, Prof, Istanbul University, Cardiology Institute, Cardiology Department

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Gamze Baskent, Pincipal İnvestigator, Istanbul University
ClinicalTrials.gov Identifier:
NCT03420209
Other Study ID Numbers:
  • 1493
First Posted:
Feb 5, 2018
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Gamze Baskent, Pincipal İnvestigator, Istanbul University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2022